Maturity-onset diabetes of the young: recent findings indicate insulin resistance/obesity are not factors.
Maturity-onset diabetes of the young (MODY) is a relatively rare subtype of type 2 diabetes characterized by an early age of onset and autosomal dominant inheritance. Unlike type 2 diabetes, which is often associated with insulin resistance, MODY is caused by a primary defect in pancreatic beta-cell function resulting in a decrease in insulin secretion. Obesity is not a feature of MODY. However, environmental stressors that increase the demand for insulin, such as illness or puberty, may unmask the genetically limited insulin secretory reserve of the undiagnosed MODY patient. Euglycemia is the primary goal of therapy, and diet is the cornerstone of glycemic control. Sulfonylureas and/or exogenous insulin may also be required depending on the degree of dysfunction of the beta cells.
Cabanas
E A
EA
Department of Internal Medicine, University of Texas Medical Branch at Galveston 77555-1188, USA.
D000328:Adult; D017668:Age of Onset; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance; D009765:Obesity / Q000150:complications*; D012307:Risk Factors